Corporate News
Darwin Express｜Wan Long, Deputy Secretary of Beijing Shijingshan District Committee and Mayor of Shijingshan District, visited our company for special investigation.
Darwin Bio's Chairman Wang Yu honored as "Beijing March 8 Red Flag Woman": Illuminating New Hope for Life with the Light of Science and Technology
Clinical Study of Alitol for Acute Ischemic Stroke (ASSIST) Launched
Subject Recruitment-A Clinical Controlled Study of the Safety and Efficacy of Alitol Transdermal Microneedling for Recovery from Idiopathic Facial Nerve Palsy
Darwin statue lands at Darwin Bio - a perfect blend of art and technology
A new starting point and a new journey to open a new chapter for 2025!
Beijing Municipal Association of Science and Technology Innovation Service Center to help regional innovation and development series of activities - Neural Repair Technology Innovation and Industrial Integration and Upgrading Seminar Series, the fourth session was successfully held!
The "Joint Laboratory for Translational Technology of Tachyphylaxis and Neural Repair" was officially inaugurated!
Interview | Innovative drug lights up nerve repair
Darwin Cell Biology appointed Dr. Mi Liu as Chief Scientific Officer!
Darwin Cell Biology was honored as one of the "2024 Top 10 Scientific and Technological Innovations in Neuropsychiatry" at the Health Industry Innovation Summit!
Beijing Darwin Cell Biotechnology Co., Ltd. announced the successful implementation of key steps in the divestment and transfer of the consumer healthcare segment of its business!
2024 United Nations Civil Society Conference (2024 UNCSC) video version
The 2024 United Nations Civil Society Conference (2024 UNCSC) was successfully organized!
Molecular and Cellular Neurobiology Section of the 2024 Gordon Research Conference Successfully Organized in Lucca, Italy
Darwin's Starting Point Biologic "DEW003" Opens Clinical Trial for Alzheimer's Disease Treatment
[Special announcement] on the innovative biologic drug "Alito"
English 
Chinese